Aeterna Zentaris, Inc. (USA) (NASDAQ:AEZS)

CAPS Rating: 4 out of 5

A growing global biopharmaceutical company focused on endrocrine therapy and oncology, in drug discovery, development and commercialization.

Recs

14
Player Avatar OneStarHero (< 20) Submitted: 6/4/2007 9:23:30 PM : Outperform Start Price: $3.71 AEZS Score: -77.80

This is a sure thing, chech this out:AETERNA ZENTARISswap some letters around...ZANIEST EARN RATE

Report this Post 1 Comment
Member Avatar SewellMarbury (64.45) Submitted: 1/17/2008 4:01:39 PM
Recs: 0

That gives me a chuckle every time I see it.

Featured Broker Partners


Advertisement